Mohammad Alanazi

ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer

S. Rose-John, M. Tate, B. Jenkins, 2019, EMBO molecular medicine.

Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1β axes bridge innate immunity and epithelial apoptosis to promote emphysema

S. Rose-John, B. Jenkins, P. King, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Blockade of the protease ADAM17 ameliorates experimental pancreatitis

Linden J. Gearing, S. Rose-John, B. Jenkins, 2022, Proceedings of the National Academy of Sciences of the United States of America.